Table 1 Demographic and clinical characteristics of the study groups

Age

62.7 ± 13

60.1 ± 11.9

0.38

Male, n (%)

31 (68.9%)

18 (50%)

0.08

Current smoker, n(%)

11 (24.4%)

2 (5.6%)

0.02 *

HTN, n(%)

8 (17.8%)

11 (30.6%)

0.18

Type 1 DM, n (%)

2 (4.4%)

4(11.1%)

0.4

Type 2 DM, n (%)

7(5.6%)

4(11.1%)

0.56

Total Cholesterol (mg/dL)

189.2 ± 43.7

176.3 ± 32.3

0.14

LDL-C (mg/dL)

112.8 ± 35.6

106 ± 28.7

0.36

HDL-C (mg/dL)

46.2 ± 11.4

42.3 ± 10

0.11

LDL/HDL ratio

4.23

4.24

0.96

Triglyceride (mg/dL)

146.1 ± 97.6

153 ± 105.5

0.76

ANV (ng/mL)

0.84 ± 0.93

4.12 ± 2.88

0.003*

aANVAs(ng/mL)

33.2 ± 55

17.8 ± 54.4

0.2

Positive aANVAs

20(45.5%)

6(15.8%)

0.004*

aCLAs(ng/mL)

21.7 ± 55.7

13.9 ± 38.1

0.46

Positive aCLAs

8(18.6%)

5(13.2%)

0.53